You just read:

Vtesse, Inc. Announces Preliminary Data from Ongoing Phase 1 Study of VTS-270 for Treatment of Niemann-Pick Disease Type C

News provided by

Vtesse, Inc.

06 Aug, 2015, 12:30 BST